Market Place
Sourcing Support
Novartis Reports Earnings Miss Due To Generic Competition
28 Apr 2026 //
REUTERS
Novartis` Lutathera Radioligand Therapy Faces Generic Rivals
23 Apr 2026 //
ENDPOINTS
India Revokes Patent of Novartis` Blockbuster Cardiac Drug
16 Sep 2025 //
ECONOMICTIMES
Novartis boosts FY 2025 core income outlook on robust Q2 sales
17 Jul 2025 //
GLOBENEWSWIRE
Novartis Loses Bid to Block Us Entresto Generic Through 2026
14 Jul 2025 //
REUTERS
US Entresto Generic Unblocked as Novartis Loses Bid till 2026
11 Jul 2025 //
REUTERS
Novartis Asks Court for Swift Decision in Entresto Patent Case
07 Jun 2025 //
FIERCE PHARMA
Apotex Launches Generic Tasigna Capsules in Us with Exclusivity
27 May 2025 //
PR NEWSWIRE
Novartis wins 11th-hour bid to block Entresto generic from MSN
17 Jan 2025 //
FIERCE PHARMA
Novartis wins temporary pause to Entresto generic launch in US
16 Jan 2025 //
REUTERS
Novartis` latest bid to block MSN`s generic comes up short
06 Dec 2024 //
FIERCE PHARMA
Judge upholds MSN`s generic Entresto nod amid Novartis challenge
19 Oct 2024 //
FIERCE PHARMA
Novartis loses latest bid to block generic version of blockbuster heart drug
17 Oct 2024 //
REUTERS
Novartis loses initial bid to block generic of best-selling heart drug
13 Aug 2024 //
REUTERS
Ex-Sandoz exec gets probation for price-fixing after cooperation deal
16 May 2024 //
REUTERS
US FDA mandates label updates on CAR-T cancer therapies
19 Apr 2024 //
REUTERS
Novartis unveils new brand identity after Sandoz spinoff
06 Dec 2023 //
ENDPTS
Sandoz inks deal to commercialize biosim to J&J`s Stelara
12 Sep 2023 //
FIERCE PHARMA
Novartis adjusts business unit names in preparation for Sandoz generics
08 Sep 2023 //
ENDPTS
Roche sues Novartis unit over generic lung disease drug
02 Aug 2023 //
REUTERS
Novartis will let generic Tasigna to be provided to poor nations
23 Jun 2023 //
FIERCE PHARMA
MPP signs on four generics makers to make Novartis` Tasigna more accessible
22 Jun 2023 //
ENDPTS
Novartis heart drug price may fall by 60% on generic rollouts
19 Jan 2023 //
ECONOMIC TIMES
Novartis pays $245M to settle Exforge generic pay-for-delay suit
04 Jan 2023 //
FIERCE PHARMA
Novartis to pay $245 mln to end antitrust cases over Exforge drug generics
30 Dec 2022 //
REUTERS
Novartis files another Entresto patent suit to fight generics
27 Oct 2022 //
FIERCEPHARMA
Novartis` Sandoz embarks on €150M antibiotics manufacturing upgrade in Europe
19 May 2021 //
FIERCE PHARMA
Novartis sues FDA, claiming Sanofi`s Aubagio isn`t really new
12 Mar 2021 //
FIERCE PHARMA
Attorneys general bring another ‘collusion’ case against generic makers
12 Jun 2020 //
ENDPTS
States file 3rd generics price-fixing suit against 26 firms
11 Jun 2020 //
FIERCEPHARMA
Pressure on generic drugmakers increases with new price fixing lawsuit
10 Jun 2020 //
BIOPHARMADIVE
Novartis shells out $195M in generics price-fixing settlement
03 Mar 2020 //
FIERCE PHARMA
Sandostatin LAR can steer clear of generics in 2020: Novartis
04 Feb 2020 //
FIERCE PHARMA
Novartis tips complex manufacturing to insulate Sandostatin from generics
04 Feb 2020 //
IN-PHARMATECHNOLOGIST
Novartis gives up on Advair generic, leaving Mylan as sole competitor
31 Jan 2020 //
BIOPHARMADIVE
Sandoz-Aurobindo, Zolgensma, AZ and more
25 Oct 2019 //
FIERCE PHARMA
Where is that Sandoz U.S. generics deal with Aurobindo?
24 Oct 2019 //
FIERCE PHARMA
Novartis recall of generic Zantac probably first of many
24 Sep 2019 //
FIERCE PHARMA
Digital Dose Inhalers Market-Opportunities With AstraZeneca, Novartis,Technavio
20 Sep 2019 //
BUSINESSWIRE
Novartis doesn`t wait for FDA, halts distribution of its generic
20 Sep 2019 //
FIERCE PHARMA
Novartis, Lonza deepen biosimilars push with MS, arthritis drug deals
04 Sep 2019 //
REUTERS
FDA says widening probe on generic drug impurities
29 Aug 2019 //
REUTERS
Pfizer`s Lyrica market share crumbles under generic onslaught
20 Aug 2019 //
FIERCE PHARMA
Lawmakers urge DoJ to get moving on generic price fixing probe
17 Jun 2019 //
FIERCE PHARMA
AstraZeneca`s Faslodex gets U.S. generic on heels of record sales year
31 May 2019 //
FIERCE PHARMA
Novartis Corp. v. West-Ward Pharmaceuticals Int`l (Fed. Cir. 2019)
17 May 2019 //
PATENTDOCS
Novartis defeats challenge to validity of Afinitor patent
15 May 2019 //
REUTERS
In lawsuit, United Therapeutics is accused of unfairly blocking generic rival
22 Apr 2019 //
POST
Sandoz takes United Therapeutics to court for `anticompetitive` behavior
21 Apr 2019 //
BIOPHARMADIVE
Novartis Pharmaceuticals Corp. v. Par Pharmaceutical Inc.
19 Apr 2019 //
PATENDOCS
Old guard` generics players yield U.S. scripts lead
18 Apr 2019 //
FIERCE PHARMA
Amid spinoff talk, Novartis generics biz licenses Shionogi brand
11 Apr 2019 //
FIERCE PHARMA
China May Save $30 Billion With Generic-Drug Plan, Novartis Says
05 Apr 2019 //
BLOOMBERG
Generics take aim at United`s top-selling Remodulin
28 Mar 2019 //
FIERCE PHARMA
Novartis generics boss quits amid conjecture over business’s future
14 Mar 2019 //
CNBC
Tropical Disease PRV Fix Didn’t Stop Novartis From Winning Another
16 Feb 2019 //
RAPS
Manufacturing cuts likely in remake of Sandoz
02 Feb 2019 //
FIERCE PHARMA
Novartis plots new course for Sandoz
01 Feb 2019 //
BIOCENTURY
‘De-intergration’ of Sandoz from Novartis expected to include manufacturing cuts
01 Feb 2019 //
FIERCE PHARMA
